DE3381437D1 - Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung. - Google Patents

Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung.

Info

Publication number
DE3381437D1
DE3381437D1 DE8383303331T DE3381437T DE3381437D1 DE 3381437 D1 DE3381437 D1 DE 3381437D1 DE 8383303331 T DE8383303331 T DE 8383303331T DE 3381437 T DE3381437 T DE 3381437T DE 3381437 D1 DE3381437 D1 DE 3381437D1
Authority
DE
Germany
Prior art keywords
hypoglykaemic
dione
effect
sub
substituted oxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383303331T
Other languages
German (de)
English (en)
Inventor
Gerald Fagan Holland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3381437D1 publication Critical patent/DE3381437D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/42—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/45—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8383303331T 1982-06-23 1983-06-09 Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung. Expired - Lifetime DE3381437D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/391,220 US4430337A (en) 1982-06-23 1982-06-23 Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity

Publications (1)

Publication Number Publication Date
DE3381437D1 true DE3381437D1 (de) 1990-05-17

Family

ID=23545772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383303331T Expired - Lifetime DE3381437D1 (de) 1982-06-23 1983-06-09 Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung.

Country Status (10)

Country Link
US (1) US4430337A (enExample)
EP (1) EP0097453B1 (enExample)
JP (1) JPS5916881A (enExample)
AT (1) ATE51864T1 (enExample)
CA (1) CA1197513A (enExample)
DE (1) DE3381437D1 (enExample)
DK (1) DK287883A (enExample)
ES (1) ES523521A0 (enExample)
GR (1) GR79300B (enExample)
IE (1) IE55837B1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
TW268952B (enExample) 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
TW403748B (en) 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
EP1194146B1 (en) 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
US6380191B1 (en) 1999-06-18 2002-04-30 Merck & Co. Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB226529A (en) 1923-12-18 1925-08-13 Arnold I Van Den Bergh S Embal Improvements in and relating to edge trimming and moulding machines for planks and laths
US2338064A (en) 1940-02-10 1943-12-28 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349796A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349795A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349313A (en) 1943-03-01 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2, 4-oxazolidinedione
US2575692A (en) 1947-10-11 1951-11-20 Abbott Lab N-methyl oxazolidine-2, 4-diones
US2575694A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5, 5-trimethyloxazolidine-2, 4-dione
US2575693A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5-dimethyl-5-ethyloxazolidine-2, 4-dione
US2961377A (en) 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3699229A (en) * 1970-12-18 1972-10-17 Abbott Lab 2-oxo-5-phenyl-4-oxazolidinone as an anti-depressant agent
US4200642A (en) 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
GT198170554A (es) * 1980-07-28 1983-01-12 5-oxazolidin-2-4-dionas hipoglicemicas substituidas.
US4332952A (en) 1980-07-28 1982-06-01 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones

Also Published As

Publication number Publication date
JPS5916881A (ja) 1984-01-28
US4430337A (en) 1984-02-07
JPS6230993B2 (enExample) 1987-07-06
IE831461L (en) 1983-12-23
DK287883D0 (da) 1983-06-22
EP0097453A3 (en) 1985-06-12
CA1197513A (en) 1985-12-03
EP0097453B1 (en) 1990-04-11
IE55837B1 (en) 1991-01-30
ATE51864T1 (de) 1990-04-15
ES8500918A1 (es) 1984-11-01
EP0097453A2 (en) 1984-01-04
GR79300B (enExample) 1984-10-22
ES523521A0 (es) 1984-11-01
DK287883A (da) 1983-12-24

Similar Documents

Publication Publication Date Title
SE8104542L (sv) Hypoglykemiska 5-substituerade oxazolidin-2,4-dioner
DE3381465D1 (de) Sebum-auffang und steuermittel.
ATE51864T1 (de) Alicyclische substituierte oxazolidin-2,4-dione mit hypoglykaemischer wirkung.
ATE139900T1 (de) Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
DE3876143D1 (de) Wegwerfbare infusionskassette mit pumpenkammer sowie triebwerk dafuer.
DK641889D0 (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
IT8120742A0 (it) Procedimento e dispositivo per migliorare la planarita' di fette sottili lucidate.
FI98324B (fi) Miehittämättömien sukellusalusten käyttämä moduuli vedenalaisten putkijohtojen käsittelemiseksi, jatkamiseksi ja korjaamiseksi
DK19284A (da) Infusion af frugt
AU7343581A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
NO161513C (no) Fremgangsmaate til fremstilling av enkeltkrystallmaterialemed kontrollert krystallografisk orientering.
FR2333226A1 (fr) Dispositif perfectionne pour la reception d'energie rayonnante, notamment sous forme de rayons infrarouges
IT7926834A0 (it) Procedimento e dispositivo di lancio di fili all'inizio di incannatura.
AU526733B2 (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
IT1196988B (it) Policarbonati ramificati contenenti composti metilen-bis-naftalenici e procedimento per la loro preparazione
IT8321885A0 (it) Procedimento di isomerizzazione con l'uso di glucosio isomerasi.
FR2355505A1 (fr) Nouvel agent adjuvant immunitaire
IT7927611A0 (it) Procedimento per la ricottura ottica a due lunghezze d'onda dimateriali.
DE58908815D1 (de) Monoklonaler Antikörper gegen Pseudomonas aeruginosa, seine Herstellung und Verwendung.
ES513508A0 (es) "un aparato para su uso en el ajuste de la regulacion de la inyeccion de combustible".
IT1121010B (it) Procedimento per la carbonilazione di diolefine
DK192890A (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
IT7927663A0 (it) Procedimento per la polimerizzazione di butene-1.
AU555134B2 (en) Intermediates in the preparation of 5-substituted oxazolidine-2, 4-diones
JPS5330729A (en) Dc damping system for induction motor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee